Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Clovis Oncology Inc (CLVSQ)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Clovis historical data, for real-time data please try another search
0.016 +0.000    +0.00%
10/07 - Delayed Data. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.010 - 0.017
Type:  Equity
Market:  United States
Clovis 0.016 +0.000 +0.00%

Clovis (CLVSQ) Earnings Dates & Reports

 
On this page, you can find detailed information about the financial performance of Clovis Oncology Inc, including the latest Clovis earnings report and upcoming earnings date. The page provides an overview of the company's financial health, with key data points such as the current Clovis Oncology Inc stock price, CLVSQ EPS (earnings per share), and revenue compared against the forecast.

To view advanced CLVSQ earnings and revenue information, investors can sign up for their very own InvestingPro Account.
InvestingPro Earnings Insights
Latest Release

Aug 02, 2023

EPS / Forecast

-- / --

Revenue / Forecast

-- / --

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Aug 02, 2023 06/2023 -- /  -- -- /  --
May 03, 2023 03/2023 -- /  -- -- /  --
Feb 22, 2023 12/2022 -- /  -0.2529 -- /  30.52M
Nov 09, 2022 09/2022 -0.39 /  -0.4 30.66M /  32.57M
Aug 08, 2022 06/2022 -0.5 /  -0.4148 32.14M /  37.17M
May 04, 2022 03/2022 -0.44 /  -0.4325 34.25M /  36.97M
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CLVSQ Price Commentary

Write your thoughts about Clovis Oncology Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Svetljo Svetljo
Svetljo Svetljo Nov 22, 2022 20:16
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any news ?
Reply
0 0
Report
Arminvest Net
Arminvest Net Jul 05, 2022 12:27
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
33 soon
Reply
2 0
Report
John Rollings
John Rollings Apr 20, 2022 14:54
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna SHOOT RIGHT UP !
Reply
1 0
Report
John Rollings
John Rollings Apr 20, 2022 14:46
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
A company does not host a webcast to announce poor financial results ! They only do that when the results are really good ! This is gonna *****!
Reply
1 0
Report
John Rollings
John Rollings Apr 20, 2022 14:44
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4 4/20/2022 BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its rst quarter 2022 nancial results on Wednesday, May 4, 2022, before the open of the US nancial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30am ET to discuss the Company’s results in greater detail. The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days. Dial-in numbers for the conference call are as follows: US participants 888.440.4615, International participants 646.960.0682, conference ID: 2259685
Reply
1 0
Report
John Rollings
John Rollings Apr 11, 2022 19:51
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NOT LONG BEFORE PFIZER OR A SIMILAR BIG PHARMA SNAPS THIS UP AND SHARES WORTH 10 X WHAT THEY ARE NOW AT $2.48 IN MY OPINION DYOR Clovis Oncology’s Rubraca® (Rucaparib) Signicantly Improves Progression-Free Survival in First-line Maintenance Treatment in Women with Ovarian Cancer Regardless of Their Biomarker Status in Phase 3 ATHENA-MONO Trial 3/31/2022 https://s22.q4cdn.com/778348918/files/doc_news/Clovis-Oncologys-Rubraca-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-C16N4.pdf
Reply
1 0
Report
Co Co
Co Co Mar 24, 2021 21:40
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Clvs might be next gme apparently
Reply
1 0
Report
Co Co
Co Co Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Shouldnt be to quiet today
Reply
0 0
Report
L X Apurbo Vai
L X Apurbo Vai Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what
Reply
0 0
Report
Co Co
Co Co Mar 19, 2021 13:39
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sorry my reply to an old comment
Reply
0 0
Report
Peter Gowler
Peter Gowler Feb 26, 2021 14:27
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
quite in here lol
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email